Full video transcriptClick to expand
Auto-generated transcript of @gracefully_gab's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Let's take a break from skinny and as if we talk for a bit.
- 0:02And in honor of Mother's Day, appreciate a real first-partner body.
- 0:06I am two years, almost three years first-partum.
- 0:11Three babies, stretch marks, stretch marks.
- 0:21Flab and ole. This is the story of how my babies got here.
- 0:28Honor Mother's Day. I'm gonna remind you to take some time out.
- 0:32Give yourself some grace.
- 0:33Appreciate your body. I've carried you through a pregnancy lab with a level of everything in it.
- 0:41There's no...
- 0:43You stretch marks and not agree without the story of how your babies came to be.
- 0:48So appreciate it.
- 0:48And happy Mother's Day.
Ozempic, postpartum bodies, and what GLP-1 drugs actually do
Quick answer
The creator makes no clinical claims, instead offering a postpartum body acceptance message that implicitly critiques GLP-1 drug trends on social media. The psychological literature supports the premise that idealized postpartum body imagery on social media worsens body dissatisfaction and is linked to postpartum anxiety and disordered eating. GLP-1 medications like semaglutide are not currently approved for use during breastfeeding, and their postpartum-specific risk-benefit profile requires individualized clinical evaluation rather than social media guidance in either direction.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Ozempic, postpartum bodies, and what GLP-1 drugs actually do, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Ozempic, postpartum bodies, and what GLP-1 drugs actually do" from graceful_gab. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator makes no clinical claims, instead offering a postpartum body acceptance message that implicitly critiques GLP-1 drug trends on social media.
The reason this review is not generic is the source wording and the canonical claim label "glp1 social media keeps pushing perfect postpartum bodies ozempic." In this clip, the useful excerpt is: "Let's take a break from skinny and as if we talk for a bit." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator makes no clinical claims, instead offering a postpartum body acceptance message that implicitly critiques GLP-1 drug trends on social media.
FormBlends verdict
Compounded Semaglutide safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator makes no clinical claims, instead offering a postpartum body acceptance message that implicitly critiques GLP-1 drug trends on social media. The psychological literature supports the premise that idealized postpartum body imagery on social media worsens body dissatisfaction and is linked to postpartum anxiety and disordered eating. GLP-1 medications like semaglutide are not currently approved for use during breastfeeding, and their postpartum-specific risk-benefit profile requires individualized clinical evaluation rather than social media guidance in either direction.
- Striae gravidarum (stretch marks) affect an estimated 50-90% of pregnant women and are a normal dermal response to skin stretching, not a sign of inadequate care (Atwal et al., 2006, JAAD).
- Diastasis recti, abdominal separation that contributes to postpartum softness, affects up to 60% of women postpartum and is a structural adaptation, not a failure of fitness (Lee and Hodges, 2016, JOSPT).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- Striae gravidarum (stretch marks) affect an estimated 50-90% of pregnant women and are a normal dermal response to skin stretching, not a sign of inadequate care (Atwal et al., 2006, JAAD).
- Diastasis recti, abdominal separation that contributes to postpartum softness, affects up to 60% of women postpartum and is a structural adaptation, not a failure of fitness (Lee and Hodges, 2016, JOSPT).
- Higher exposure to idealized postpartum body content on social media is independently associated with greater body dissatisfaction at 12 months postpartum (Coyne et al., 2023, Body Image).
- GLP-1 medications including semaglutide and tirzepatide are not currently approved for use while breastfeeding, making postpartum use a conversation that requires a licensed clinical provider.
- Self-compassion, the core practice Gab models in this video, is associated with reduced postpartum depression and anxiety risk in peer-reviewed literature (Biaggi et al., 2016, Journal of Affective Disorders).
- Body acceptance and evidence-based medical care for postpartum metabolic conditions are not mutually exclusive. Women with gestational diabetes histories, for example, have elevated type 2 diabetes risk that warrants clinical follow-up regardless of body image stance.
- The 'bounce back' expectation has no scientific basis as a postpartum health standard. Postpartum physiological recovery timelines vary widely and are influenced by delivery method, breastfeeding status, genetics, and sleep deprivation.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @gracefully_gab actually say?
Gab didn't make any medical claims. She made a values argument. Nearly three years postpartum with three children, she pushed back against what she called the pressure to have a "skinny" body and told viewers to "give yourself some grace" and "appreciate your body." That's the whole thesis. No diet advice, no drug recommendations, no pseudoscience.
The video lands squarely in body acceptance territory, and the implicit critique is aimed at social media's current obsession with GLP-1 drugs like semaglutide (Ozempic, Wegovy) as postpartum weight loss tools. She didn't name a drug specifically, but the caption references "Ozempic trends" directly. Worth keeping that context in mind when evaluating what she's actually arguing against.
Does the science back this up?
On the core claim, yes. The psychological research on postpartum body image is pretty consistent: social media exposure to idealized postpartum bodies is associated with worse body dissatisfaction, and that dissatisfaction has real clinical consequences.
A 2023 study by Coyne et al. in Body Image found that postpartum women who engaged more heavily with appearance-focused social media content reported significantly higher body dissatisfaction and lower self-compassion scores at 12 months postpartum. A 2021 review by Pudney et al. in Women and Birth documented that the expectation to "bounce back" rapidly after childbirth is tied to elevated rates of postpartum anxiety and disordered eating behaviors. Gab's instinct that social media pressure is doing real harm to postpartum women is not just a vibe. It's a documented phenomenon.
What the research also shows is that self-compassion interventions, the kind of thinking Gab is modeling, are associated with better postpartum mental health outcomes (Biaggi et al., 2016, Journal of Affective Disorders).
What did they get wrong (or right)?
Honestly, she got the emotional argument right. There's nothing medically inaccurate in what she said because she didn't make medical claims. She made a cultural argument, and that argument is well-supported.
Where things get more complicated is the implicit framing around GLP-1 drugs. Gab positions Ozempic culture as the villain opposite authentic postpartum acceptance. That's a legitimate cultural critique, but it risks oversimplifying a real clinical picture. GLP-1 receptor agonists are not just vanity tools. For postpartum women with obesity-related conditions, type 2 diabetes, or gestational-diabetes histories, these medications can be clinically appropriate. A 2023 trial by Davies et al. in The Lancet showed tirzepatide produced meaningful cardiometabolic improvements in people with obesity, not just weight loss for aesthetic reasons.
Framing all GLP-1 use as "surgery culture" or trend-chasing doesn't serve women who might have legitimate medical reasons to discuss these options with a doctor. The criticism of social media's pressure on postpartum bodies is valid. The implicit "all weight loss tools are the enemy" framing is a bit reductive.
What should you actually know?
A few things worth separating out here. First, postpartum body changes are physiologically expected and well-documented. Diastasis recti affects up to 60% of women postpartum (Lee and Hodges, 2016, Journal of Orthopaedic and Sports Physical Therapy). Skin laxity, stretch marks (striae gravidarum), and fat redistribution are normal structural adaptations to pregnancy. None of these require medical intervention unless they're causing functional problems.
Second, if you're postpartum and genuinely concerned about metabolic health, weight, or mood, those concerns deserve a real clinical evaluation, not a TikTok trend in either direction. GLP-1 medications are not approved for use while breastfeeding, and their postpartum safety profile is still being studied. That's a conversation for a licensed provider, not an influencer.
Third, body acceptance and medical care are not mutually exclusive. You can appreciate your postpartum body and also want to address a health condition. The either-or framing that social media loves, either you're body-positive or you're doing Ozempic, is a false choice. Most people's lives are more nuanced than that.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
graceful_gab · TikTok creator
1.2K views on this video
Social media keeps pushing “perfect” postpartum bodies, Ozempic trends & surgery culture… meanwhile this is what a REAL postpartum body looks like 🤍 Nearly 3 years postpartum, 3 babies later, stretch marks, softness, flab and all. And you know what? My body still deserves love, grace and appreciation. Your body carried life. It carried pregnancies, labor, sleepless nights, healing, motherhood and every moment in between. Those stretch marks are not flaws.. they’re proof of strength, sacrifice
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about striae gravidarum (stretch marks) affect an estimated 50-90% of pregnant?
Striae gravidarum (stretch marks) affect an estimated 50-90% of pregnant women and are a normal dermal response to skin stretching, not a sign of inadequate care (Atwal et al., 2006, JAAD).
What does the video say about diastasis recti, abdominal separation?
Diastasis recti, abdominal separation that contributes to postpartum softness, affects up to 60% of women postpartum and is a structural adaptation, not a failure of fitness (Lee and Hodges, 2016, JOSPT).
What does the video say about higher exposure to idealized postpartum body content on social media?
Higher exposure to idealized postpartum body content on social media is independently associated with greater body dissatisfaction at 12 months postpartum (Coyne et al., 2023, Body Image).
What does the video say about glp-1 medications including semaglutide?
GLP-1 medications including semaglutide and tirzepatide are not currently approved for use while breastfeeding, making postpartum use a conversation that requires a licensed clinical provider.
What does the video say about self-compassion, the core practice gab models in this video,?
Self-compassion, the core practice Gab models in this video, is associated with reduced postpartum depression and anxiety risk in peer-reviewed literature (Biaggi et al., 2016, Journal of Affective Disorders).
What does the video say about body acceptance?
Body acceptance and evidence-based medical care for postpartum metabolic conditions are not mutually exclusive. Women with gestational diabetes histories, for example, have elevated type 2 diabetes risk that warrants clinical follow-up regardless of body image stance.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by graceful_gab, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.